chr5-177210575-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022455.5(NSD1):​c.2176T>C​(p.Ser726Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.164 in 1,613,816 control chromosomes in the GnomAD database, including 26,158 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2412 hom., cov: 31)
Exomes 𝑓: 0.16 ( 23746 hom. )

Consequence

NSD1
NM_022455.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.437

Publications

61 publications found
Variant links:
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome due to NSD1 mutation
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Sotos syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • Sotos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.151531E-4).
BP6
Variant 5-177210575-T-C is Benign according to our data. Variant chr5-177210575-T-C is described in ClinVar as Benign. ClinVar VariationId is 96043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSD1NM_022455.5 linkc.2176T>C p.Ser726Pro missense_variant Exon 5 of 23 ENST00000439151.7 NP_071900.2 Q96L73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSD1ENST00000439151.7 linkc.2176T>C p.Ser726Pro missense_variant Exon 5 of 23 1 NM_022455.5 ENSP00000395929.2 Q96L73-1

Frequencies

GnomAD3 genomes
AF:
0.161
AC:
24486
AN:
151918
Hom.:
2416
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.0870
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.122
Gnomad EAS
AF:
0.509
Gnomad SAS
AF:
0.278
Gnomad FIN
AF:
0.219
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.150
Gnomad OTH
AF:
0.141
GnomAD2 exomes
AF:
0.202
AC:
50878
AN:
251400
AF XY:
0.201
show subpopulations
Gnomad AFR exome
AF:
0.105
Gnomad AMR exome
AF:
0.245
Gnomad ASJ exome
AF:
0.127
Gnomad EAS exome
AF:
0.517
Gnomad FIN exome
AF:
0.216
Gnomad NFE exome
AF:
0.145
Gnomad OTH exome
AF:
0.175
GnomAD4 exome
AF:
0.165
AC:
240943
AN:
1461780
Hom.:
23746
Cov.:
38
AF XY:
0.167
AC XY:
121658
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.0972
AC:
3255
AN:
33480
American (AMR)
AF:
0.234
AC:
10469
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
3351
AN:
26136
East Asian (EAS)
AF:
0.504
AC:
20026
AN:
39698
South Asian (SAS)
AF:
0.252
AC:
21711
AN:
86254
European-Finnish (FIN)
AF:
0.217
AC:
11578
AN:
53418
Middle Eastern (MID)
AF:
0.151
AC:
870
AN:
5768
European-Non Finnish (NFE)
AF:
0.143
AC:
159275
AN:
1111910
Other (OTH)
AF:
0.172
AC:
10408
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
12374
24749
37123
49498
61872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5920
11840
17760
23680
29600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.161
AC:
24482
AN:
152036
Hom.:
2412
Cov.:
31
AF XY:
0.169
AC XY:
12545
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.107
AC:
4423
AN:
41494
American (AMR)
AF:
0.181
AC:
2762
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
422
AN:
3468
East Asian (EAS)
AF:
0.509
AC:
2622
AN:
5156
South Asian (SAS)
AF:
0.278
AC:
1340
AN:
4814
European-Finnish (FIN)
AF:
0.219
AC:
2311
AN:
10564
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.150
AC:
10192
AN:
67966
Other (OTH)
AF:
0.141
AC:
298
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1022
2045
3067
4090
5112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
9428
Bravo
AF:
0.153
TwinsUK
AF:
0.135
AC:
499
ALSPAC
AF:
0.133
AC:
512
ESP6500AA
AF:
0.103
AC:
452
ESP6500EA
AF:
0.138
AC:
1191
ExAC
AF:
0.199
AC:
24113
Asia WGS
AF:
0.353
AC:
1225
AN:
3478
EpiCase
AF:
0.143
EpiControl
AF:
0.131

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29083408) -

Inborn genetic diseases Benign:1
Mar 19, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Sotos syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.073
.;T;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.59
T;T;.
MetaRNN
Benign
0.00082
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
.;M;.
PhyloP100
0.44
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.99
N;N;N
REVEL
Benign
0.16
Sift
Uncertain
0.013
D;D;D
Sift4G
Benign
0.15
T;T;T
Polyphen
1.0
D;D;D
Vest4
0.080
MPC
0.066
ClinPred
0.0056
T
GERP RS
1.3
Varity_R
0.093
gMVP
0.36
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28932178; hg19: chr5-176637576; COSMIC: COSV61770821; COSMIC: COSV61770821; API